孫學軍教授 : 氢生物医学研究
In recent years, China’s hydrogen molecular biomedical research has achieved fruitful results, basic research and clinical research level continues to promote, in the prevention of atherosclerosis, lower cholesterol and so made a lot of progress.
This is the Chinese Medical Association of Hydrogen Molecular Biomedical Committee Chairman of the Second Military Medical University Professor Sun Xuejun September 25 held in Taian, Shandong Taishan Academic Forum – Hydrogen Biomedical and Elderly Chronic Disease and Chinese Medical Association of Hydrogen Molecular Biology Medical Society of the third session of the academic conference on the expression.
Dr. Sun Xuejun, Progress on Hydrogen Biomedicine Research
Professor Sun Xuejun pointed out that since 2007, since the beginning of hydrogen molecular medicine research hotspot, China’s molecular research team of hydrogen molecular medicine has been expanding, the industrialization of rapid progress. At present, more than 970 papers published in this field, about 500 published by Chinese scholars. As of the end of 2015, the National Natural Science Foundation supported 57 molecular studies of hydrogen molecular medicine in the skin, tumor radiotherapy side effects, diabetes, B liver and other diseases to accelerate the clinical study, which in the treatment of uremia, the treatment of Parkinson’s disease As well as the prevention of atherosclerosis, lower cholesterol research has made great progress.
Among them, the Taishan Medical College atherosclerosis Institute and Beijing vitality hydrogen source biotechnology Co., Ltd. and other units to carry out the results of hydrogen medicine research also won the second prize of scientific and technological progress in Shandong Province, director of the Institute of Atherosclerosis Professor Qin Shucun team through the ” Double-blind placebo-controlled trial “to prove that hydrogen in the treatment of dyslipidemia and arteriosclerosis significantly.
According to reports, the conference by the Shandong Provincial Department of Education and the Taian city government, from Japan, the United States, South Korea and the domestic more than 300 experts and scholars and industry participants.
All along, there are scholars and business people want to prove that hydrogen can treat cancer, but I have been on the role of hydrogen in the treatment of cancer care, why, in the end hydrogen can treat cancer, or how can prove that hydrogen can treat cancer? From an academic point of view, there is indeed evidence of hydrogen therapy for cancer.
BEIJING, July 23 (Xinhua) Chinese scholars confirmed that saturated hydrogen water (also known as “rich water”) on the treatment of human metabolic syndrome, to achieve a breakthrough in the field of clinical research in molecular medicine. In addition, Chinese scholars in the field of molecular medicine research published in the world’s total number of papers accounted for one-third of the leading position.
September 19, by the Hebei Province in the elderly health care association, Hebei Province Mental Health Association, the Chinese Association for the elderly health care dementia and related diseases professional committee, the China Health Management Federation brain health committee hosted the “Shijiazhuang first international heart and brain health forum” Held in Shijiazhuang People’s Hall.
On April 16, the World Association of Thoracic Medicine “Hydrogen Molecular Medicine and Pulmonary Diseases” satellite will be held in Shanghai, the satellite will be sponsored by the China International Medical Exchange Foundation, Shanghai, the United States and the United States Medical Technology Co., Ltd., Chinese Academy of Engineering Zhong Nanshan, Fudan University Affiliated Zhongshan Hospital Professor Bai Chunxue presided over, experts, scholars and medical professionals about 500 people attended the meeting.
In 2016, the international clinical blood lipid and ASCVD research field has made a number of major clinical research results and important clinical management guidelines, the prevention and treatment of ASCVD provides an extremely important evidence, and further research for the future provides an important clue. In this paper, a brief review of several clinical practice may have a significant impact on the study and its results.
At the end of 2016, Japan’s Ministry of Health, Labor and Welfare announced the inclusion of “hydrogen-absorbing therapy for cardiac arrest” in the “Advanced Medical Class B” system. Japan’s “advanced medical care” is a treatment method that is under the prerequisite of being incorporated into the medical system applicable to Japanese health insurance. Japan subsequently conducted a medical trial study of 360 patients with 20 medical institutions using 2% concentration of hydrogen.
Precision medicine, more accurate teaching should be called accurate diagnosis, one of the important branch of the study of gene changes can lead to disease, but in fact accurate medical treatment can not be simply equivalent to gene sequencing. When we talk about precision medical care, we always hope to bring rapid diagnosis and treatment, in fact, we have no way to diagnose the transition to the treatment of disease overnight.
Prospects in the field of medicine Hydrogen is a common chemical element in nature, ranked first in the periodic table, and is the smallest atom of nature. Hydrogen is the simplest form of molecular material in hydrogen. Hydrogen tasteless, colorless, odorless, with a certain degree of reduction, and the reaction of oxygen to produce water.
(In addition, the Canadian Traditional Chinese Medicine International Forum was held in the MEC Conference Hall in Greater London on October 10, 2014) The 20th anniversary of the Canadian Traditional Chinese Medicine International Symposium and the 20th anniversary of the All-China Chinese Medicine Acupuncture and Moxibustion Association was held on August 10 Held in the MEC Conference Hall in Wanjin City, Toronto, Canada, with more than 450 professionals in the field of Chinese medicine and acupuncture and moxibustion.
The editorial was sponsored by the China Cardiovascular Health Alliance “Xinxin Cardiovascular Health Foundation” on April 21, 2017, and the “dyslipidemia and atherosclerosis research project project” (referred to as “fund”) supported by Merck The twentieth session of the National Involvement in Cardiology Forum was officially launched.